![[Arg8] - Vasopressin (AVP)](/media/com_eshop/products/resized/prod_150x150-500x500.png "[Arg8] - Vasopressin (AVP)")
Call Now: +1 858 800 3101 Email: info@innopep.com
Shopping Cart
0 Item(s) - $0.00
Your shopping cart is empty!
[Arg8] - Vasopressin (AVP)
| Overview | |
|---|---|
| Description | AVP have been identified as an important regulator of fluid and electrolyte homeostasis through its anti-diuretic action on the kidney, After myocardial infarction, plasma levels of [Arg8]-vasopressin rise to recover hemodynamics. |
| Sequence | CYFQNCPRG-NH2 (Disulfide bridge: 1-6) |
| Sequence (3 Letter) | H-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2 (Disulfide bridge: 1-6) |
| Molecular Weight | 1084.3 |
| Properties | |
| Purity | > 95% By HPLC |
| Storage | Store at -20 °C, cap vial tightly at all times. |
Ref: Iwadate, M. et al. Eur. J. Biochem. 267, 4504 (2000); Creba, JA. et al. Biochem. J. 212, 733 (1983); Teranishi, Y. et al. Jpn. J. Pharmacol. 79, 251 (1999); Lankhuizen, I. et al. J. Cardiovasc. Pharmacol. 36, 38 (2000); Barthelmebs, M. et al. Eur. J. Pharmacol. 314, 325 (1996); Hashimoto, H. et al. Neuropeptides 12, 199 (1988); Gieldon, J. Comput. Aided Mol. Des. 15, 1085 (2001).
About InnoPep
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.